rapid
accur
detect
respiratori
syncyti
viru
rsv
provid
pathogenspecif
diagnosi
allow
implement
appropri
infect
control
measur
improv
patient
manag
one
diagnost
challeng
respiratori
infect
caus
sever
viral
pathogen
includ
rsv
usual
present
similar
sign
symptom
nearli
indistinguish
clinic
diagnosi
describ
chapter
rapid
highthroughput
laboratori
techniqu
detect
panel
common
viral
pathogen
one
singl
reaction
combin
targetenrich
multiplex
pcr
amplif
luminex
suspens
array
identif
common
respiratori
virus
includ
rsv
b
influenza
viru
b
parainfluenza
viru
human
metapneumoviru
rhinovirus
enterovirus
sar
coronaviru
detect
differenti
simultan
within
five
hour
respiratori
syncyti
viru
rsv
known
lead
caus
bronchiol
pneumonia
infant
young
children
ill
begin
frequent
rhinorrhea
sneez
cough
children
experi
recoveri
ill
day
first
rsv
infect
infect
infant
young
children
sign
symptom
bronchiol
pneumonia
requir
hospit
highrisk
group
prone
sever
rsv
diseas
includ
prematur
infant
children
congenit
heart
chronic
lung
diseas
immunosuppress
patient
congenit
immunodefici
requir
hospit
clinic
manifest
outcom
rsv
caus
hazard
nosocomi
infect
produc
outbreak
year
widespread
infect
children
adult
includ
medic
personnel
may
mild
enough
ill
caus
absenc
work
furthermor
spread
viru
facilit
number
young
infant
admit
outbreak
tend
shed
high
titer
viru
prolong
period
virus
mimic
rsv
infect
includ
adenovirus
influenza
viru
inf
b
parainfluenza
virus
piv
human
metapneumoviru
hmpv
rhinovirus
patient
acut
respiratori
infect
present
similar
sign
symptom
regardless
viral
pathogen
clinic
differenti
diagnosi
infect
caus
virus
difficult
earli
accur
virusspecif
laboratori
diagnosi
significantli
enhanc
patient
manag
current
varieti
laboratori
test
avail
detect
differenti
respiratori
virus
develop
last
two
decad
use
rapid
test
diagnosi
rsv
infect
allow
implement
appropri
infect
control
measur
thu
reduc
nosocomi
spread
may
use
consider
time
treatment
aerosol
ribavirin
sever
case
direct
fluoresc
antibodi
dfa
test
good
sensit
rsv
good
respiratori
virus
rapid
eia
antigen
test
avail
rsv
influenza
b
easi
perform
rapid
dfa
slightli
lower
sensit
specif
among
respiratori
virus
mention
previous
vast
major
grown
tradit
viral
cultur
cell
line
use
clinic
virolog
laboratori
except
hmpv
yet
wide
use
routin
diagnost
laboratori
furthermor
cell
cultur
slow
turnaround
time
virus
show
detect
cytopath
effect
day
later
howev
shell
vial
techniqu
incorpor
mix
fresh
cell
rmix
diagnost
hybrid
inc
athen
oh
perform
speed
turnaround
time
day
sensit
similar
convent
cell
cultur
diagnosi
rsv
infect
use
serolog
practic
applic
clinic
use
case
respiratori
viral
pathogen
molecular
assay
base
vitro
nucleic
acid
amplif
implement
gradual
clinic
laboratori
rsv
detect
molecular
assay
led
pcr
gener
demonstr
superior
routin
diagnost
method
term
high
sensit
specif
especi
use
adult
patient
viral
shed
short
low
cell
cultur
remain
gold
standard
rsv
diagnosi
molecular
assay
consid
platinum
standard
use
refer
valid
new
diagnost
kit
rsv
detect
howev
organismspecif
monoplex
assay
resourceintens
respiratori
viral
infect
consid
list
possibl
etiolog
necessarili
long
multiplex
rtpcrbase
techniqu
wide
report
simultan
detect
panel
respiratori
viral
pathogen
singl
reaction
sever
product
includ
hexaplex
assay
prodess
waukesha
wi
plxrvp
assay
eragen
bioscienc
madison
wi
idtag
rvp
tm
bioscienc
toronto
canada
resplex
ii
qiagen
valencia
ca
commerci
avail
chapter
describ
complet
molecular
diagnost
procedur
cover
common
rna
viral
pathogen
caus
respiratori
tract
infect
follow
procedur
consist
three
compon
fig
first
specimen
process
nucleic
acid
extract
done
use
easymag
autom
total
nucleic
acid
extract
instrument
biomerieux
durham
nc
base
magnet
silica
particlebas
techniqu
kit
avail
biomerieux
work
varieti
clinic
specimen
includ
nasopharyng
swab
aspir
yield
high
quantiti
qualiti
total
nucleic
acid
second
nucleic
acid
amplif
use
targetenrich
multiplex
tem
pcr
contain
two
nest
primer
set
organ
set
super
primer
simultan
amplifi
infa
infb
rsva
rsvb
hmpv
rhinovirus
rhv
enterovirus
env
sever
acut
respiratori
syndrom
sar
coronaviru
cov
gene
singl
reaction
tube
target
gene
virus
list
tabl
third
amplicon
detect
identif
reach
use
microspherebas
liquid
array
luminex
austin
tx
median
fluoresc
intens
mfi
report
target
posit
cutoff
use
determin
sampl
posit
particular
target
last
amplif
detect
compon
includ
resplex
ii
kit
avail
qiagen
durham
nc
geneamp
pcr
system
appli
biosystem
use
emul
mode
begin
extract
request
enter
sampl
type
sampl
entri
confirm
type
sampl
set
primari
defin
sampl
volum
elut
volum
extract
nasal
collect
program
ml
sampl
volum
ml
elut
volum
ensur
protocol
gener
sampl
enter
press
organ
run
icon
oppos
arrow
creat
new
run
press
new
run
icon
sun
enter
run
name
press
ok
creat
run
layout
use
arrow
icon
arrang
sampl
list
correct
order
run
press
load
run
instrument
bottl
icon
place
sampl
tray
pipett
tip
correct
posit
use
barcod
scanner
scan
posit
sampl
tray
posit
press
printer
icon
print
run
press
ok
print
window
appear
pull
sampl
tube
instrument
place
metal
sampl
rack
pipett
ml
sampl
sampl
tube
use
printout
guid
finish
place
sampl
tray
back
instrument
posit
sampl
tray
scan
instrument
close
lid
sampl
modul
press
add
lysi
icon
lysi
buffer
ad
instrument
incub
approxim
min
sampl
lyse
instrument
prepar
magnet
silica
prepar
magnet
silica
use
multichannel
pipett
choos
program
press
select
button
display
press
enter
run
continu
sampl
complet
finish
display
bar
bottom
screen
run
progress
label
tube
sampl
control
longterm
storag
complet
run
press
view
result
icon
magnifi
glass
report
print
window
pop
read
run
result
print
mark
run
assess
press
ye
quickli
check
report
error
error
signal
repeat
extract
refer
troubleshoot
use
ampcheck
reagent
first
time
make
dilut
ad
ml
rnasefre
water
tube
contain
ml
ampcheck
mix
make
sure
thermal
cycler
preheat
place
sampl
unit
thaw
templat
rna
dntp
mix
qiagen
onestep
rtpcr
buffer
rnasefre
water
place
ice
note
import
mix
solut
complet
use
avoid
local
differ
salt
concentr
prepar
detect
mix
accord
tabl
tabl
provid
exampl
data
resplex
ii
tabl
exampl
run
posit
cutoff
depend
instrument
softwar
use
analysi
cutoff
valu
target
determin
sum
mean
plu
four
time
standard
deviat
neg
control
set
rtpcr
reaction
ice
rna
target
fragil
keep
reaction
mix
cold
reduc
rna
degrad
use
dispos
rnasefre
tip
contain
hydrophob
filter
minim
crosscontamin
use
geneamp
pcr
system
appli
biosystem
run
emul
mode
amplif
step
recommend
perform
protocol
use
equip
verifi
yet
begin
hybrid
procedur
detect
step
detect
reaction
must
kept
analysi
liquichip
workstat
protect
resplex
ii
bead
mix
reaction
mix
light
foil
use
cover
tube
plate
clinic
valid
studi
archiv
frozen
nasopharyng
swab
aspir
sensit
specif
rsv
detect
compar
standard
combin
cell
cultur
monoplex
realtim
taqman
pcr
sensit
specif
respect
respiratori
virus
full
panel
test
run
handson
time
test
turnaround
time
estim
min
h
respect
valid
data
enteroviru
rhinoviru
crossreact
resplex
assay
sampl
test
posit
parainfluenza
eight
sampl
imf
valu
higher
cutoff
valu
assay
use
detect
recogn
viral
coinfect
usual
relat
sever
clinic
manifest
respiratori
dna
virus
bocaviru
adenoviru
recent
report
respiratori
polyomaviru
cover
resplex
ii
kit
evalu
studi
new
version
resplex
ii
kit
cover
bocaviru
adenoviru
addit
describ
chapter
avail
qiagen
sinc
juli
